{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:20:37Z","timestamp":1790713237741,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ijrobp.2012.08.043","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T21:06:18Z","timestamp":1354827978000},"page":"22-32","source":"Crossref","is-referenced-by-count":162,"title":["Hepatocellular Carcinoma Radiation Therapy: Review of Evidence and Future Opportunities"],"prefix":"10.1016","volume":"87","author":[{"given":"Jonathan","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2012.08.043_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"Ca Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib2","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1158\/1055-9965.EPI-11-0643","article-title":"International trends in liver cancer incidence rates","volume":"20","author":"Center","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib3","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/gast.2002.33411","article-title":"Hepatocellular carcinoma: Diagnosis and treatment","volume":"122","author":"Befeler","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1440-1746.2005.03746.x","article-title":"Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery","volume":"20","author":"Huang","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3747\/co.v18i5.952","article-title":"Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma","volume":"18","author":"Sherman","year":"2011","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib6","series-title":"Robbins and Cotran pathologic basis of disease","author":"Kumar","year":"2009"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib7","series-title":"Handbook of evidence-based radiation oncology","author":"Hansen","year":"2010"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/SLA.0b013e31820508f1","article-title":"Liver transplantation for\u00a0advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion","volume":"253","author":"DuBay","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib10","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib11","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib14","first-page":"19","article-title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial","volume":"19","author":"Bruix","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib15","unstructured":"Cheng A, Kang Y, Lin D, et\u00a0al. Phase III trial of sunitinib (Su) versus sorafenib (So) in advanced hepatocellular (HCC). 2011 ASCO Annual Meeting Chicago, IL;\u00a02011."},{"issue":"19","key":"10.1016\/j.ijrobp.2012.08.043_bib16","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1001\/jama.2010.1672","article-title":"Doxorubicin plus sorafenib\u00a0vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial","volume":"304","author":"Abou-Alfa","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.semradonc.2011.05.009","article-title":"Overview: Where does radiation therapy fit in the spectrum of liver cancer local-regional therapies?","volume":"21","author":"Dawson","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib18","series-title":"Investigation of Early Liver Radiation Injury Using Resovist-Enhanced MRI at 3T","author":"Jao","year":"2010"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10334-004-0087-z","article-title":"Relationship between tumour growth rate and carbogen-based functional MRI for a chemically induced HCC in mice","volume":"17","author":"Thomas","year":"2004","journal-title":"MAGMA"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1478-3231.2005.01094.x","article-title":"Radiotherapy for painful bone metastases from hepatocellular carcinoma","volume":"25","author":"Seong","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib21","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/j.1572-0241.1998.00614.x","article-title":"Radiotherapy for osseous metastases from hepatocellular carcinoma: A retrospective study of 57 patients","volume":"93","author":"Kaizu","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib22","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/cncr.21811","article-title":"Radiation therapy for hepatocellular carcinoma: From palliation to cure","volume":"106","author":"Hawkins","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10585-011-9442-4","article-title":"Palliative radiation therapy for pulmonary metastases from hepatocellular carcinoma","volume":"29","author":"Jiang","year":"2012","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib24","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib25","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1200\/JCO.2005.01.5354","article-title":"Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies","volume":"23","author":"Ben-Josef","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib26","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ijrobp.2006.06.015","article-title":"Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies\u2014mature results of the French Phase II RTF-1 trial","volume":"66","author":"Mornex","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1478-3231.2008.01873.x","article-title":"A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea","volume":"29","author":"Seong","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/jjco\/hyh089","article-title":"Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization","volume":"34","author":"Liu","year":"2004","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib29","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/cncr.21012","article-title":"Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma","volume":"103","author":"Liang","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib30","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3109\/02841869509127197","article-title":"Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients","volume":"34","author":"Blomgren","year":"1995","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","article-title":"Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"26","author":"Tse","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib32","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1002\/cncr.26404","article-title":"Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma","volume":"118","author":"Price","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib33","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/j.ijrobp.2011.04.011","article-title":"Stereotactic body radiotherapy for primary hepatocellular carcinoma","volume":"81","author":"Andolino","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/1471-2407-10-475","article-title":"Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer","volume":"10","author":"Kwon","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12094-010-0492-x","article-title":"Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma","volume":"12","author":"Cardenes","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jso.21593","article-title":"Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma","volume":"102","author":"Seo","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/153303461000900506","article-title":"Stereotactic radiotherapy of hepatocellular carcinoma: Preliminary results","volume":"9","author":"Louis","year":"2010","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/1471-2407-8-351","article-title":"Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis","volume":"8","author":"Choi","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/02841860600897934","article-title":"Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase I-II study","volume":"45","author":"Mendez Romero","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib40","first-page":"23439","article-title":"Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation","volume":"29","author":"O'Connor","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.semradonc.2011.05.007","article-title":"Charged-particle therapy for hepatocellular carcinoma","volume":"21","author":"Skinner","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib42","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1002\/cncr.24619","article-title":"Proton beam therapy for hepatocellular carcinoma: The University of Tsukuba experience","volume":"115","author":"Nakayama","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib43","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1002\/cncr.25809","article-title":"The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: A phase 2 prospective trial","volume":"117","author":"Bush","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib44","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1002\/cncr.26134","article-title":"Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma","volume":"117","author":"Komatsu","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib45","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ijrobp.2010.07.015","article-title":"Proton beam therapy for hepatocellular carcinoma: A comparison of three treatment protocols","volume":"81","author":"Mizumoto","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib46","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ijrobp.2010.03.015","article-title":"Proton beam therapy for hepatocellular carcinoma located adjacent to the alimentary tract","volume":"80","author":"Nakayama","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib47","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ijrobp.2009.02.030","article-title":"Proton beam therapy for large hepatocellular carcinoma","volume":"76","author":"Sugahara","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.radonc.2010.05.019","article-title":"Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis","volume":"96","author":"Imada","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib49","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ijrobp.2008.10.073","article-title":"A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma","volume":"74","author":"Fukumitsu","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib50","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s00066-009-2020-x","article-title":"Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis","volume":"185","author":"Sugahara","year":"2009","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib51","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijrobp.2007.09.056","article-title":"Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis","volume":"71","author":"Mizumoto","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib52","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ijrobp.2007.04.016","article-title":"Proton beam therapy for aged patients with hepatocellular carcinoma","volume":"69","author":"Hata","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib53","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00066-006-1564-2","article-title":"Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis","volume":"182","author":"Hata","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib54","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/cncr.22039","article-title":"Proton beam therapy for hepatocellular carcinoma with limited treatment options","volume":"107","author":"Hata","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib55","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1200\/JCO.2005.00.620","article-title":"Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma","volume":"23","author":"Kawashima","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib56","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/cncr.21237","article-title":"Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus","volume":"104","author":"Hata","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib57","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1158\/1078-0432.CCR-04-1350","article-title":"Proton beam therapy for hepatocellular carcinoma: A retrospective review of 162 patients","volume":"11","author":"Chiba","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib58","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.ijrobp.2004.01.032","article-title":"Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis","volume":"59","author":"Kato","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib59","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1245\/s10434-007-9787-8","article-title":"Treatment before liver transplantation for HCC","volume":"15","author":"Belghiti","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/153303460900800601","article-title":"Stereotactic radiotherapy of the liver: A bridge to transplantation","volume":"8","author":"Al Hamad","year":"2009","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib61","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1432-2277.2009.00980.x","article-title":"Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma","volume":"23","author":"Sandroussi","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib62","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijrobp.2011.08.032","article-title":"Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: Clinical outcome and pathologic correlation","volume":"83","author":"Katz","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.ijrobp.2012.08.043_bib63","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/01.RVI.0000182185.47500.7A","article-title":"Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis","volume":"16","author":"Georgiades","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib64","first-page":"237","article-title":"[Radiation therapy of hepatocellular carcinoma]","volume":"86","author":"Takagi","year":"1989","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib65","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ijrobp.2008.06.1486","article-title":"The treatment responses in cases of radiation therapy to portal vein thrombosis in advanced hepatocellular carcinoma","volume":"73","author":"Huang","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib66","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jjco\/hys082","article-title":"Effectiveness of high-dose three-dimensional conformal radiotherapy in hepatocellular carcinoma with portal vein thrombosis","volume":"42","author":"Rim","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib67","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.ijrobp.2011.03.019","article-title":"Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: Long-term patient outcomes","volume":"82","author":"Yoon","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib68","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1440-1746.2011.06745.x","article-title":"Efficacy of therapy for advanced hepatocellular carcinoma: Intra-arterial 5-fluorouracil and subcutaneous interferon with image-guided radiation","volume":"26","author":"Chuma","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib69","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s00535-009-0033-y","article-title":"Intra-arterial 5-fluorouracil\/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis","volume":"44","author":"Katamura","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib70","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/cncr.24139","article-title":"Hepatocellular carcinoma with main portal vein tumor thrombus: treatment with 3-dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization","volume":"115","author":"Zhang","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib71","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/cncr.23684","article-title":"Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis","volume":"113","author":"Han","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib72","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.radonc.2007.07.005","article-title":"Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma","volume":"84","author":"Toya","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib73","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/jjco\/hyl006","article-title":"Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy","volume":"36","author":"Lin","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib74","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/cncr.21043","article-title":"Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma","volume":"103","author":"Kim","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib75","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ijrobp.2004.05.025","article-title":"A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and\/or inferior vena cava tumor thrombus","volume":"61","author":"Zeng","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib76","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0360-3016(03)00434-6","article-title":"Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma","volume":"57","author":"Yamada","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib77","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00000421-200204000-00019","article-title":"Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus","volume":"25","author":"Ishikura","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib78","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1440-1746.2001.02496.x","article-title":"Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement","volume":"16","author":"Tazawa","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib79","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1440-1746.2009.06110.x","article-title":"Intra-arterial 5-fluorouracil\/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases","volume":"25","author":"Katamura","year":"2010","journal-title":"J Gastoenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib80","doi-asserted-by":"crossref","unstructured":"Bujold A, Massey C, Kim J, et\u00a0al. Outcomes following sequential trials of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC). ASCO Annual Meeting. Chicago, IL;\u00a02011.","DOI":"10.1200\/jco.2011.29.15_suppl.4111"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib81","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1259\/bjr\/33521596","article-title":"Combined therapy of transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinoma","volume":"80","author":"Zhou","year":"2007","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib82","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00130404-200409000-00008","article-title":"A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma","volume":"10","author":"Zeng","year":"2004","journal-title":"Cancer J"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib83","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3748\/wjg.v9.i8.1697","article-title":"Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma","volume":"9","author":"Guo","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib84","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijrobp.2009.10.070","article-title":"Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma: An irradiation dose escalation study","volume":"79","author":"Ren","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib85","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijrobp.2009.07.1730","article-title":"Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus","volume":"78","author":"Koo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib86","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1478-3231.2005.01170.x","article-title":"Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma","volume":"25","author":"Shim","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib87","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/COC.0b013e3181b0c298","article-title":"Early three-dimensional conformal radiotherapy for patients with unresectable hepatocellular carcinoma after incomplete transcatheter arterial chemoembolization: a prospective evaluation of efficacy and toxicity","volume":"33","author":"Oh","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib88","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1002\/cncr.24552","article-title":"Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma","volume":"115","author":"McIntosh","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib89","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijrobp.2008.08.034","article-title":"Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases","volume":"74","author":"Jang","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib90","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2009.07.1725","article-title":"Angiogenic blockade and radiotherapy in hepatocellular carcinoma","volume":"78","author":"Chi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib91","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semradonc.2011.05.003","article-title":"Hepatic radiation toxicity: Avoidance and amelioration","volume":"21","author":"Guha","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib92","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2004.05.048","article-title":"Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease","volume":"60","author":"Cheng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib93","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ijrobp.2007.04.005","article-title":"Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma","volume":"69","author":"Kim","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib94","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib95","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canrad.2007.12.007","article-title":"The evolving role of radiation therapy in hepatocellular carcinoma","volume":"12","author":"Dawson","year":"2008","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2012.08.043_bib96","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ijrobp.2009.09.009","article-title":"Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: Dose-volumetric parameters predicting the hepatic complication","volume":"78","author":"Son","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301612035109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301612035109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T19:43:00Z","timestamp":1562442180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301612035109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0360301612035109"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2012.08.043","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}